Imexpharm Corp
VN:IMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Imexpharm Corp
Cost of Revenue
Imexpharm Corp
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Imexpharm Corp
VN:IMP
|
Cost of Revenue
-₫1.4T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Cost of Revenue
-₫2.2T
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Cost of Revenue
-₫1.1T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-9%
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Cost of Revenue
-₫1.7T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-7%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Cost of Revenue
-₫2.8T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Cost of Revenue
-₫1.2T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
Imexpharm Corp
Glance View
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
See Also
What is Imexpharm Corp's Cost of Revenue?
Cost of Revenue
-1.4T
VND
Based on the financial report for Dec 31, 2025, Imexpharm Corp's Cost of Revenue amounts to -1.4T VND.
What is Imexpharm Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Imexpharm Corp have been -15% over the past three years , -12% over the past five years , and -9% over the past ten years .
